TheEdgeResearch
Home / Stocks / MDCN

Medican Enterprises, Inc. (MDCN)

OTC Healthcare Medical - Pharmaceuticals
$0.00 ▲ +0.00%
Market Cap
$2.9M
Sector
Healthcare
Industry
Medical - Pharmaceuticals
Beta
-3.96
52-Wk Range
0.0001-0.0001
CEO
Mitchell Xavier
Country
US
Currency
USD

Medican Enterprises, Inc. operates in the Medical - Pharmaceuticals industry of the Healthcare sector, headquartered in Woodland Hills, CA, US. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $2.9M. On trailing twelve-month figures it carries a trailing P/E of -3.38, a net margin of 0.0%. Its beta of -3.96 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
-3.38
Price / Sales
0.00
Price / Book
0.14
EV / EBITDA
-18.70
Gross margin
0.0%
Operating margin
0.0%
Net margin
0.0%
Return on equity
—
Debt / equity
0.70
Current ratio
0.00
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
3
IPO date
1995-02-21
Headquarters
Woodland Hills, CA, US
About Medican Enterprises, Inc.

Medican Enterprises, Inc. focuses on sports and entertainment investments, holding stakes in basketball franchises, digital media assets, and sports-related non-fungible tokens (NFTs). The company offers basketball team ownership, sports real estate interests, media content, and digital collectibles. It also manages and develops basketball teams; produces and licenses sports-related media content, including documentaries, video games, and digital content; creates and manages NFTs and other digital collectibles; and provides strategic investment opportunities and consulting services. Medican Enterprises, Inc. was incorporated in 1988 and is headquartered in Las Woodland Hills, California.

Comparable companies

Medican Enterprises, Inc. is most often compared with the following Healthcare names:

BRSTCDJMCRDVECROENTIFUTLIDVVMSPCRGSGTPHS
More research on MDCN
MDCN technical analysis MDCN TheEdge Score Compare against peers
Open full interactive analysis & DCF →